Wohua Pharmaceuticals announced that revenue for the first half of 2026 was 393 million yuan, a year-on-year decrease of 7.53%. Net profit was 67.5663 million yuan, up 51.23% year on year. The company's profit distribution plan reviewed and approved by the board of directors is: based on 577 million yuan, a cash dividend of 1.17 yuan will be distributed to all shareholders for every 10 shares, 0 bonus shares will be given, and the share capital will not be transferred from the Provident Fund.

Wohua Pharmaceuticals announced that revenue for the first half of 2026 was 393 million yuan, a year-on-year decrease of 7.53%. Net profit was 67.5663 million yuan, up 51.23% year on year. The company's profit distribution plan reviewed and approved by the board of directors is: based on 577 million yuan, a cash dividend of 1.17 yuan will be distributed to all shareholders for every 10 shares, 0 bonus shares will be given, and the share capital will not be transferred from the Provident Fund.